| Nr. | Year OPEN | Title | users say> | rate good | rate bad | no link | Citation |
ChemopreventionFenretinideNeoplasia (Inherited)DifluoromethylornithineDeguelinNatural productsNeoplasia (Carcinogenesis)MetforminHormesisLung (Neoplasm)RexinoidColon and rectum (Neoplasia)Ursodeoxycholic acid| 1 | 2007 | Cancer chemopreventive effects of lactic acid bacteria. | 
| + | - | nl | J Microbiol Biotechnol 17(8):1227-35 (2007) |
| 2 | 2007 | Aspirin chemoprevention in patients with increased risk for colorectal cancer: a cost-effectiveness analysis. | 
| + | - | nl | Aliment Pharmacol Ther 26(3):431-41 (2007) |
| 3 | 2006 | Meta-analysis: antioxidant supplements for primary and secondary prevention of colorectal adenoma. | 
| + | - | nl | Aliment Pharmacol Ther 24(2):281-91 (2006) |
| 4 | 2004 | Review article: chemoprevention of colorectal cancer. | 
| + | - | nl | Aliment Pharmacol Ther 19(1):1-24 (2004) |
| 5 | 2001 | Review article: the prevention of colorectal cancer. | 
| + | - | nl | Aliment Pharmacol Ther 15(3):323-36 (2001) |
| 6 | 2010 | Systematic review: molecular chemoprevention of colorectal malignancy by mesalazine. | 
| + | - | nl | Aliment Pharmacol Ther 31(2):202-9 (2010) |
| 7 | 2007 | Review article: Helicobacter pylori eradication for the prevention of gastric cancer. | 
| + | - | nl | Aliment Pharmacol Ther 26 Suppl 2(-):25-35 (2007) |
| 8 | 2004 | Review article: the chemoprevention of colorectal carcinoma. | 
| + | - | nl | Aliment Pharmacol Ther 20 Suppl 4(-):31-5 (2004) |
| 9 | 2004 | Review article: the aetiopathogenesis of inflammatory bowel disease--immunology and repair mechanisms. | 
| + | - | nl | Aliment Pharmacol Ther 20 Suppl 4(-):9-17 (2004) |
| 10 | 2008 | Dithiolethiones for cancer chemoprevention: where do we stand? | 
| + | - | nl | Mol Cancer Ther 7(11):3470-9 (2008) |
| 11 | 2007 | Targeting the AKT protein kinase for cancer chemoprevention. | 
| + | - | nl | Mol Cancer Ther 6(8):2139-48 (2007) |
| 12 | 2006 | Fenretinide in the prevention of breast cancer in premenopausal women: fluke or fact? | 
| + | - | nl | Ann Oncol 17(7):1035-6 (2006) Pritchard KI |
| 13 | 2008 | Induction of oxidative stress as a mechanism of action of chemopreventive agents against cancer. | 
| + | - | nl | Br J Cancer 98(7):1157-60 (2008) |
| 14 | 2004 | Chemoprevention of cancer. | 
| + | - | nl | CA Cancer J Clin 54(3):150-80 (2004) |
| 15 | 1995 | Chemoprevention. | 
| + | - | nl | CA Cancer J Clin 45(1):31-49 (1995) |
| 16 | 1999 | Chemoprevention in hereditary colorectal cancer syndromes. | 
| + | - | nl | Cancer 86(11 Suppl):2551-63 (1999) |
| 17 | 2005 | Chemoprevention of melanoma: theoretical and practical considerations. | 
| + | - | nl | Cancer Control 12(4):219-22 (2005) |
| 18 | 2009 | Use of 5-alpha-reductase inhibitors for prostate cancer chemoprevention: American Society of Clinical Oncology/American Urological Association 2008 Clinical Practice Guideline. | 
| + | - | nl | J Clin Oncol 27(9):1502-16 (2009) |
| 19 | 1999 | Development of difluoromethylornithine (DFMO) as a chemoprevention agent. | 
| + | - | nl | Clin Cancer Res 5(5):945-51 (1999) |
| 20 | 2009 | Total and cancer mortality after supplementation with vitamins and minerals: follow-up of the Linxian General Population Nutrition Intervention Trial. | 
| + | - | nl | J Natl Cancer Inst 101(7):507-18 (2009) |
| 21 | 2005 | Deguelin as a chemopreventive agent in mouse lung tumorigenesis induced by tobacco smoke carcinogens. | 
| + | - | nl | J Natl Cancer Inst 97(22):1634-5 (2005) |
| 22 | 1994 | Chemoprevention of carcinogen-DNA adducts and chronic degenerative diseases. | 
| + | - | nl | Cancer Res 54(7 Suppl):1994s-1998s (1994) |
| 23 | 1994 | Anticarcinogenic activities of organic isothiocyanates: chemistry and mechanisms. | 
| + | - | nl | Cancer Res 54(7 Suppl):1976s-1981s (1994) |
| 24 | 1987 | Rationale and strategies for chemoprevention of cancer in humans. | 
| + | - | nl | Cancer Res 47(11):3012-31 (1987) |
| 25 | 1985 | Chemoprevention of cancer. | 
| + | - | nl | Cancer Res 45(1):1-8 (1985) |
| 26 | 1966 | Chemoprophylaxis of carcinogenesis: a review. | 
| + | - | nl | Cancer Res 26(7):1520-6 (1966) |
| 27 | 2000 | Chemoprevention of cancer. | 
| + | - | nl | Carcinogenesis 21(3):525-30 (2000) |
| 28 | 1998 | Aromatase inhibitors as potential cancer chemopreventives. | 
| + | - | nl | Cancer Epidemiol Biomarkers Prev 7(1):65-78 (1998) |
| 29 | 1999 | Lipoxygenase inhibitors as potential cancer chemopreventives. | 
| + | - | nl | Cancer Epidemiol Biomarkers Prev 8(5):467-83 (1999) |
| 30 | 1994 | Chemopreventive drug development: perspectives and progress. | 
| + | - | nl | Cancer Epidemiol Biomarkers Prev 3(1):85-98 (1994) |
| 31 | 2010 | Molecular targets of dietary phenethyl isothiocyanate and sulforaphane for cancer chemoprevention. | 
| + | - | nl | AAPS J 12(1):87-97 (2010) |
| 32 | 2011 | Interactions between Hsp90 and oncogenic viruses: implications for viral cancer therapeutics. | 
| + | - | nl | Am J Cancer Res 1(6):763-72 (2011) |
| 33 | 2010 | Metformin and cancer: doses, mechanisms and the dandelion and hormetic phenomena. | 
| + | - | nl | Cell Cycle 9(6):1057-64 (2010) |
| 34 | 2009 | Chemoprevention of lung cancer. | 
| + | - | nl | Proc Am Thorac Soc 6(2):187-93 (2009) |
| 35 | 2007 | Rexinoids and breast cancer prevention. | 
| + | - | nl | Clin Cancer Res 13(20):5983-7 (2007) |
| 36 | 2010 | Ursodeoxycholic acid and chemoprevention of colorectal cancer. | 
| + | - | nl | Gastroenterol Clin Biol 34(10):516-22 (2010) |